Scholars Central

Review articlePublished 28 Oct 2022

A Population Pharmacokinetic Model for Cyclosporine is Being Developed Using Therapeutic Drug Monitoring Data

Authors: Jiyan K

International Journal of Drug Development and Research

Volume 14 · Issue 10 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

To create a population pharmacokinetic model for TDM that can be used for Uruguayan patients receiving cyclosporine (CsA) medication. Methods and Patients, There were 53 patients in all who were receiving CsA treatment. The remaining 16 patients were taken into account for the evaluation of the predictive performances while the remaining 37 patients with at least one pharmacokinetic profile described with four samples were taken into consideration for model development. The Monolix software's nonlinear mixed effect modelling was used to estimate pharmacokinetic parameters, and the mlxR module in R 3.6.0 was used to run simulations. As a structural model, a two-compartment model with a first-order disposition model that takes lag time into account was adopted. Alpha-synucleinopathies and other neurodegenerative illnesses are currently being treated with therapeutic approaches that focus on increasing drug absorption into the brain. The suggested methods, such intranasal administration, should be able to get over the blood-brain barrier (BBB), and even when administered directly intracerebrally, they could need a carrier to speed up local drug release. We looked into how much alpha-synuclein aggregates there were in cultured cells using a model synthetic hydrogel that will be employed as a drug delivery system. The findings suggested that the synthetic polymer had an impact on alpha-synuclein aggregation and that it was important to examine any material's impact on the pathological process before using it as a medication carrier. Keywords Neurodegenerative; Synucleinopathies

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Drug Development and Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Drug Development and Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Jiyan K”